Autolus Therapeutics Ltd reported $-59.51M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
AstraZeneca USD 3.16B 3.95B Jun/2026
Autolus Therapeutics Ltd USD -59.51M 12.95M Mar/2026
Hikma Pharmaceutical USD 348M 31M Dec/2025
Novartis USD 4.73B 549M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Silence Therapeutics USD -12.46M 13.78M Dec/2025